Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder

Molecular Psychiatry

Volumn 1, Issue 2, 1996, Pages 121-124

  LaHoste, G J ^a   Swanson, J M ^b   Wigal, S B ^b   Glabe, C ^a   Wigal, T ^b   King, N ^c   Kennedy, J L ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

ADHD; Association analysis; Children; DNA polymorphism; DRD4; Genetics

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DRD4 PROTEIN, HUMAN;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 0030133840     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Swanson JM, McBurnett K, Christian DL, Wigal T. Stimulant medications and the treatment of children with ADHD. Adv Clin Child Psych 1995; 17: 265-322.
2. Lou HC, Henrikson L, Bruhn P, Borner H, Nielsen JB. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 1990; 46; 48-52.
3. Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis AC, Kaysen D, Hamburger SD, Rapoport JL. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 1994; 151: 1791-1796.
4. Volkow ND, Ding Y-S, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, Wolf AP. Is methylphenidate like cocaine? Arch Gen Psychiatry 1995; 52: 456-463.
5. Shaywitz BA, Yager RD, Klopper JH. An experimental model of minimal brain dysfunction (MBD) in developing rats. Science 1976; 191: 305-330.
6. Cantwell D. Psychiatric illness in families of hyperactive children. Arch Gen Psychiatry 1972; 27: 414-423.
7. Deutsch CK, Matthysse S, Swanson JM, Farkas LG. Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Child Adolesc Psychiatty 1990; 29: 189-194.
8. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C, Sprich S, Tsuang MT. Segregation analysis of attention deficit hyperactivity disorder. Psychiatr Gen 1992; 2: 257-275.
9. Stevenson J. Evidence for a genetic etiology in hyperactivity in children. Behav Gen 1992; 22: 337-344.
10. Hechtman L. Genetic and neurobiological aspects of attention deficit hyperactivity disorder: a review. J Psychiatr Neurosci 1994; 19: 193-201.
11. Civelli O, Bunzow JR, Grandy DK, Zhou Q-Y, Van Tol HHM. Molecular biology of the dopamine receptors. Eur J Pharmacol - Mol Pharmacol Section 1991; 207: 277-286.
12. Van Tol HHM, Wu CM, Guan H-C, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature 1992; 358: 149-152.
13. 4 (DRD4) gone. Hum Mol Genetics 1993; 2: 767-773.
14. Rao PA, Pickar D, Gejman PV, Ram A, Gershon ES, Gelernter J. Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch Gen Psychiatry 1994; 51: 912-917.
15. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HHM. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65: 1157-1165.
16. Van Tol HHM, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic dozapine. Nature 1991; 350: 610-614.
17. Meador-Woodruff JH, Grandy DK, Van Tol HH, Damask SP, Little KY, Civelli O, Watson SJ Jr. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 1994; 10: 239-248.
18. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. Full-length cDNA cloning and distribution of human dopamine D4 receptor. Mol Brain Res 1995; 29: 157-162.
19. Ebstein RP, Novick O, Umansky R, Priol B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nature Genetics 1996; 12: 78-88.
20. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nature Genetics 1996; 12: 81-84.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, 1994.
22. Shaffer D, Fisher P, Dulcan D et al. National Institute of Mental Health Diagnostic Interview Schedule for Children, Version 2.3 (DISC 2.3), 1992.
23. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Keiffer JE, Leventhal BL. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Gen 1995; 56: 993-998.
24. LaHoste GJ, Wigal SB, Glabe C, Cook EH, Kennedy JL, Swanson JM. Dopamine-rolated genes and attention deficit hyperactivity disorder. Soc Neurosci Abstr 1995; 21: 736.
25. Vandenbergh DJ, Persico AM, Uhl GR. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially dimorphic TaqI RFLPs. Mol Brain Res 1992; 15: 161-166.
26. Sano A, Kondoh K, Kakimoto Y, Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Gen 1993; 91: 405-406.
27. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculation. Ann Hum Gen 1987; 51: 227-233.